兩倍做多納斯達克生物科技指數ETF-ProShare
55.26
Open
Market Cap
High
Low
Close
Volume
P/E Ratio
Div/Yield
About 兩倍做多納斯達克生物科技指數ETF-ProShare
ProShares Trust - ProShares Ultra Nasdaq Biotechnology 是由 ProShare Advisors LLC 推出和管理的交易所交易基金。它投資於美國的公共股票市場。它通過衍生品投資於醫療保健、製藥、生物技術和生命科學領域公司的股票。它使用掉期等衍生品來創建其投資組合。該基金投資於多元化市值公司的成長型和價值型股票。該基金尋求通過使用完全複製技術來追踪納斯達克生物技術指數每日表現的 2 倍。 ProShares Trust - ProShares Ultra Nasdaq Biotechnology 成立於 2010 年 4 月 7 日，註冊地在美國。
Trade GPT
Similar Stocks
© 2025 Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.
Rockalpha Limited, operates from its Singapore headquarters at CapitaSky 808, 79 Robinson Road, Singapore 068897, with a regional office at Level 6, Core C, Cyberport 3, 100 Cyberport Road, Hong Kong.